Articles

Jared Weiss, MD, discusses key trials in nonsquamous non–small cell lung cancer in depth and their impact on the field.

Expert Carefully Considers New Immunotherapy Combos in Nonsquamous NSCLC

Videos

Chad Pecot, MD, assistant professor, Department of Medicine, University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, discusses the frontline standard of care in advanced squamous non–small cell lung cancer (NSCLC).

Dr. Pecot on the Frontline Standard of Care in Squamous NSCLC

Michael S. Lee, MD, assistant professor of medicine, Department of Molecular Therapeutics, UNC Lineberger Comprehensive Cancer Center, discusses tailoring treatment to tumor sidedness in patients with metastatic colorectal cancer.

Dr. Lee on Tailoring Treatment to Tumor Sidedness in mCRC

Michael S. Lee, MD, sheds light on the treatment options available in the metastatic colorectal cancer space and highlights strategies poised to improve patient outcomes.

Expert Highlights Evidence-Based Decision-Making in mCRC

Peter Voorhees, MD, discusses the clinical potential of adding daratumumab to bortezomib, lenalidomide, and dexamethasone in patients with multiple myeloma.

Daratumumab/VRd Regimen Has Practice-Changing Potential in Myeloma

Peter Voorhees, MD, professor of medicine, UNC Lineberger Comprehensive Cancer Center, discusses the safety run-in of the Griffin study looking at daratumumab in myeloma.

UNC LINEBERGER

Latest from UNC LINEBERGER

New content coming soon, please check back later.